Literature DB >> 28734941

Sleep, chronic pain, and opioid risk for apnea.

Serguei Marshansky1, Pierre Mayer2, Dorrie Rizzo3, Marc Baltzan4, Ronald Denis5, Gilles J Lavigne6.   

Abstract

Pain is an unwelcome sleep partner. Pain tends to erode sleep quality and alter the sleep restorative process in vulnerable patients. It can contribute to next-day sleepiness and fatigue, affecting cognitive function. Chronic pain and the use of opioid medications can also complicate the management of sleep disorders such as insomnia (difficulty falling and/or staying asleep) and sleep-disordered breathing (sleep apnea). Sleep problems can be related to various types of pain, including sleep headache (hypnic headache, cluster headache, migraine) and morning headache (transient tension type secondary to sleep apnea or to sleep bruxism or tooth grinding) as well as periodic limb movements (leg and arm dysesthesia with pain). Pain and sleep management strategies should be personalized to reflect the patient's history and ongoing complaints. Understanding the pain-sleep interaction requires assessments of: i) sleep quality, ii) potential contributions to fatigue, mood, and/or wake time functioning; iii) potential concomitant sleep-disordered breathing (SDB); and more importantly; iv) opioid use, as central apnea may occur in at-risk patients. Treatments include sleep hygiene advice, cognitive behavioral therapy, physical therapy, breathing devices (continuous positive airway pressure - CPAP, or oral appliance) and medications (sleep facilitators, e.g., zolpidem; or antidepressants, e.g., trazodone, duloxetine, or neuroleptics, e.g., pregabalin). In the presence of opioid-exacerbated SDB, if the dose cannot be reduced and normal breathing restored, servo-ventilation is a promising avenue that nevertheless requires close medical supervision.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apnea; Bruxism; Chronic pain; Headache; Insomnia; Management; Opioids; Sleep

Mesh:

Substances:

Year:  2017        PMID: 28734941     DOI: 10.1016/j.pnpbp.2017.07.014

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  16 in total

1.  Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep.

Authors:  Gilles J Lavigne; Alberto Herrero Babiloni; Pierre Mayer; Raoul Daoust; Marc O Martel
Journal:  J Clin Sleep Med       Date:  2020-02-13       Impact factor: 4.062

Review 2.  Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship.

Authors:  Alberto Herrero Babiloni; Beatrice P De Koninck; Gabrielle Beetz; Louis De Beaumont; Marc O Martel; Gilles J Lavigne
Journal:  J Neural Transm (Vienna)       Date:  2019-08-26       Impact factor: 3.575

3.  Prospective evaluation of sleep disturbances in chronic pancreatitis and its impact on quality of life: a pilot study.

Authors:  Awais Ahmed; Amit N Anand; Ishani Shah; William Yakah; Steven D Freedman; Robert Thomas; Sunil G Sheth
Journal:  Sleep Breath       Date:  2022-01-04       Impact factor: 2.816

4.  Past-year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study.

Authors:  Andrew S Tubbs; Sadia B Ghani; Michelle Naps; Michael A Grandner; Michael D Stein; Subhajit Chakravorty
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.324

Review 5.  Experience and sleep-dependent synaptic plasticity: from structure to activity.

Authors:  Linlin Sun; Hang Zhou; Joseph Cichon; Guang Yang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-04-06       Impact factor: 6.237

6.  In Search of a Good Night's Sleep: Hormones, Mind, Movement, and Breath.

Authors:  Cindy Geyer
Journal:  Am J Lifestyle Med       Date:  2017-12-28

7.  Pain intensity as a moderator of the association between opioid use and insomnia symptoms among adults with chronic pain.

Authors:  Mary Beth Miller; Wai Sze Chan; Ashley F Curtis; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  Sleep Med       Date:  2018-09-05       Impact factor: 3.492

8.  Opioid use, pain intensity, age, and sleep architecture in patients with fibromyalgia and insomnia.

Authors:  Ashley F Curtis; Mary Beth Miller; Himangshu Rathinakumar; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  Fractures as a suicidal behavior risk factor: A nationwide population-based cohort study.

Authors:  Chun-Hao Tsai; Wan-Ju Cheng; Chih-Hsin Muo; Tsung-Li Lin
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

10.  The influence of opioids and nonopioid central nervous system active medications on central sleep apnea: a case-control study.

Authors:  Ronald Gavidia; Amara Emenike; Anran Meng; Erica C Jansen; Shelley Hershner; Cathy Goldstein; Judy Fetterolf; Galit Levi Dunietz
Journal:  J Clin Sleep Med       Date:  2021-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.